According to The Insight Partners' research, the Asia Pacific specialty hospitals market was valued at US$ 1,45,576.34 million in 2023 and is expected to reach US$ 4,26,327.07 million by 2031, registering a CAGR of 14.4% from 2023 to 2031. Growing super specialty and multi specialty hospitals and increasing incidence of chronic diseases are among the critical factors attributed to drive the Asia Pacific specialty hospitals market growth.
Multi-specialty hospitals are hospitals offering more than two special treatments in their hospitals, whereas super specialty hospitals offer newer and newer subspecialties for a specific disorder. The physicians in multispecialty hospitals possess degrees in MD medicine, MD dermatology, and MS surgery, whereas, in super specialty hospitals, the doctors are super specialists and have degrees in DM neurology, McH urology, DM gastroenterology, McH neurosurgery super specialists--who have an education higher than an MD/MS.
Multi-specialty hospitals are the single doorways to the patient's health care needs. They offer a wide range of treatments from newborn to old-age populations. These hospitals primarily focus on prevention, disease management, and appropriate clinical interventions. Multispecialty hospitals offer numerous treatments such as general surgery, ENT, and radiology. All the different tests or consultations with another doctor are done under one roof if the patient is diagnosed with a general health condition.
Super specialty hospitals offer a wide range of specialized treatments and procedures. These types of hospitals offer different treatments, such as neurosurgery, vascular and endovascular surgery, nephrology, pulmonology, laparoscopic and gastrointestinal surgery, critical care, ophthalmology, cardiothoracic surgery, and gastroenterology. These hospitals offer an all-around spectrum of healthcare, thus providing patients with the least hassle and the most comprehensive care. They are also known to provide services such as healthcare management and research. The choice between a multispecialty and a super specialty hospital eventually depends upon the nature of the illness. Both multi-specialty and super specialty hospitals provide and promote quality care in health and wellness at an affordable cost to society. However, super specialty hospitals exist only in developed and developing countries such as the US, China, India, and the UK and do not exist in other parts of the world. Thus, with the growing healthcare needs and the rising preference for specialized treatment, super-specialty and multi-specialty hospitals are anticipated to hold several opportunities to grow during the forecast period.
On the contrary, the high costs of specialty hospitals hamper the growth of Asia Pacific specialty hospitals market.
Based on types, the Asia Pacific specialty hospitals market is segmented into pediatric hospitals, obstetrics-gynecology hospitals, ENT hospitals, oncology hospitals, rehabilitation hospitals, orthopedic hospital, neurology hospital, cardiology hospitals, IVF hospitals, and others. The neurology hospital segment held 16.8% market share in 2023, amassing US$ 24,408.83 million. It is projected to garner US$ 72,263.34 million by 2031 to register 14.2% CAGR during 2023-2031.
In terms of service type, the Asia Pacific specialty hospitals market is bifurcated into outpatient and inpatient. The inpatient segment held 65.4% share of Asia Pacific specialty hospitals market in 2023, amassing US$ 95,242.97 million. It is anticipated to garner US$ 3,00,504.54 million by 2031 to expand at 15.4% CAGR during 2023-2031.
By hospital type, the Asia Pacific specialty hospitals market is bifurcated into public hospital and private hospital. The private hospital segment held 62.2% market share in 2023, amassing US$ 90,543.32 million. It is projected to garner US$ 2,70,263.37 million by 2031 to register 14.6% CAGR during 2023-2031.
By country, the Asia Pacific specialty hospitals market is segmented into China, Japan, India, Australia, South Korea, Malaysia, Singapore, and the Rest of Asia Pacific. Our regional analysis states that China captured 25.2% share of Asia Pacific specialty hospitals market in 2023. It was assessed at US$ 36,718.77 million in 2023 and is likely to hit US$ 1,22,976.65 million by 2031, registering a CAGR of 16.3% during 2023-2031.
Key players operating in the specialty hospitals market include Advanced Specialty Hospitals; Encompass Health Corporation; Icahn School of Medicine at Mount Sinai; Indiana University Health, Inc.; Kindred Healthcare, LLC; Memorial Sloan Kettering Cancer Center; Select Medical Holdings Corp; Stanford Health Care; Steward Health Care System LLC; Universal Health Services Inc; Vibra Healthcare, LLC; Brigham and Women's Hospital; Cleveland Clinic; Community Health Systems Inc; HCA Healthcare; Johns Hopkins Medicine (Wilmer Eye Institute); McLean Hospital; and NYU Langone Hospitals among others.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com